Clinical research company Medpace Holdings (NASDAQ:MEDP) will be announcing earnings results tomorrow after market close. Here’s what you need to know. Medpace met analysts’ revenue ...

In its first quarter 2025 investor letter, Giverny Capital Asset Management highlighted stocks such as Medpace Holdings, Inc. (NASDAQ:MEDP). Medpace Holdings, Inc. (NASDAQ:MEDP) is a clinical ...

MEDP opened at $317.65 on Monday. The firm has a market cap of $9.68 billion, a PE ratio of 25.15, a P/E/G ratio of 3.81 and a beta of 1.47. The stock has a 50-day moving average price of $336.81 ...

In its first quarter 2025 investor letter, Giverny Capital Asset Management highlighted stocks such as Medpace Holdings, Inc. (NASDAQ:MEDP). Medpace Holdings, Inc. (NASDAQ:MEDP) is a clinical research ...

Shares of Medpace Holdings, Inc. (NASDAQ:MEDP – Get Free Report) have been assigned an average recommendation of “Hold” from the thirteen brokerages that are covering the company ...

TD Cowen downgraded Medpace (MEDP) to Hold from Buy with a price target of $328, down from $370. The firm cites the challenging biotech funding and uncertain regulatory environment for the downgrade.

Medpace Hldgs MEDP has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ratings ...

In its first quarter 2025 investor letter, Vulcan Value Partners emphasized stocks such as Medpace Holdings, Inc. (NASDAQ:MEDP). Medpace Holdings, Inc. (NASDAQ:MEDP) is a clinical research-based ...

Mizuho analyst Ann Hynes lowered the firm’s price target on Medpace (MEDP) to $355 from $400 and keeps an Outperform rating on the shares. The firm surveyed 215 physicians over 13 specialties to ...